that was contained in an amber 7 mL glass nasal spray with a metered pump. Placebo sprays had the same combination but did not contain oxytocin. Each pump spray delivered 50 μL of OT (9 IU) or placeb

Effectiveness of oxytocin intranasal on reducing alcohol consumption and depression syndrome in a patient with oropharyngeal carcinoma, a quasi-experimental single-case design structure

An experimental single-case design on the effectiveness of oxytocin on reducing addiction severity index in a patient with oropharyngeal squamous cell carcinoma, the mediation role of emotional dis-regulation